BRIEF-Esperion Therapeutics announces positive top line phase 2b results for ETC-1002 By: Reuters: Company News October 01, 2014 at 16:25 PM EDT * Esperion Therapeutics Announces Positive Top Line phase 2b results for ETC-1002 Read More >> Related Stocks: Esperion Theraptc Merck & Co